Hukumar Abinci da Magunguna ta Amurka (FDA) tana sane da cewa Amurka tana fuskantar babban tsangwama a cikin samar da bututun tarin jini da yawa saboda karuwar buƙatu yayin gaggawar lafiyar jama'a ta COVID-19 da ƙalubalen samar da dillalai na baya-bayan nan. .FDA tana faɗaɗa jerin ƙarancin kayan aikin likita don haɗa da duk bututun tarin jini.A baya FDA ta ba da wasiƙa ga ma'aikatan kiwon lafiya da ma'aikatan dakin gwaje-gwaje a kan Yuni10,2021, game da ƙarancin tarin samfuran jini na sodium citrate (samfurin saman shuɗi mai haske).
Shawarwari
FDA ta ba da shawarar masu ba da kiwon lafiya, daraktocin dakin gwaje-gwaje, phlebotomists, da sauran ma'aikata suyi la'akari da waɗannan dabarun kiyayewa don rage amfani da bututun jini da kiyaye inganci da amincin kulawar haƙuri:
• Yi abubuwan jan jini kawai da ake ganin ya dace a likitance. Rage gwaje-gwaje a ziyarar lafiya na yau da kullun da gwajin rashin lafiyar kawai ga waɗanda ke da takamaiman jihohin cuta ko kuma inda zai canza magani mara lafiya.
• Cire kwafin odar gwaji don guje wa jan jini mara amfani.
• Guji gwaji akai-akai ko tsawaita tazarar lokaci tsakanin gwaje-gwaje a duk lokacin da zai yiwu.
Yi la'akari da ƙarin gwaji ko raba samfuran tsakanin sassan dakin gwaje-gwaje idan akwai samfuran da aka tattara a baya.
• Idan kuna buƙatar bututu da aka jefar, yi amfani da nau'in bututu wanda ke da adadi mai yawa a wurin aikin ku.
• Yi la'akari da batun gwajin kulawa wanda baya buƙatar yin amfani da bututun tarin jini (gwajin yawo a gefe).
Ayyukan FDA
A ranar 19 ga Janairu, 2022, FDA ta sabunta jerin ƙarancin na'urorin likitanci don haɗa duk bututun tarin jini (lambobin samfur GIM da JKA).Sashe na 506J na Dokar Abinci, Drug, da Kayan kwalliya ta Tarayya (Dokar FD&C) tana buƙatar FDA ta kiyaye jerin abubuwan da ake samu a bainar jama'a, na yau da kullun na na'urorin da FDA ta ayyana suna cikin karanci.
A baya, akan:
• Yuni 10, 2021, FDA ta kara da bututun sodium citrate ( saman shuɗi mai haske) ƙarƙashin samfuran samfura iri ɗaya (GIM da JKA) zuwa cikin ƙarancin na'urar likita yayin gaggawar lafiyar jama'a ta COVID-19.
• Yuli 22, 2021, FDA ta ba da izinin amfani da gaggawa ga Becton Dickinson don wasu bututun tattara jini na sodium citrate (mai haske blue) da ake amfani da su don tattarawa, jigilar kaya, da adana samfuran jini don gwajin coagulation don mafi kyau ganewa da kuma kula da coagulopathy a cikin marasa lafiya. tare da sani ko ake zargin COVID-19.
FDA ta ci gaba da lura da halin da ake ciki yanzu don taimakawa tabbatar da gwajin jini ya kasance ga marasa lafiya inda gwajin ya zama dole.FDA za ta sanar da jama'a idan akwai sabbin bayanai masu mahimmanci.
Lokacin aikawa: Agusta-12-2022